IAPCOI-2011-13: Rollout plan Vipin M. Vashishtha, MD, FIAP Convener, 2011-13 July 16, 2011 IAP HQ, Mumbai.

Slides:



Advertisements
Similar presentations
Health and Safety Executive CONIAC, 17 July 2013 Update on CDM revision Anthony Lees Construction Policy Unit.
Advertisements

Objective of EBR related to IAPCOI 19 th February 2012, IMA House, New Delhi Vipin M. Vashishtha, MD, FIAP Convener,
Child Abuse & Neglect Work Group Meeting December 17, 2014.
IAEA International Atomic Energy Agency. IAEA Outline Learning objectives Introduction Functions of Regulatory Body (RB) on EPR Appraisal guidance: Part.
Pentavalent vaccine Introduction in UIP in India:
What is Advocacy? How Can it Help Us Achieve Our Goal?
American College of Obstetricians and Gynecologists Rebekah E. Gee MD MPH FACOG.
A global partnership to stop measles & rubella The Measles & Rubella Initiative: Preparing for the Next Decade Lisa Cairns, MD, MPH Sept 18, 2012 Washington,
CVEP Symposium: Global Vaccines 202X: Access, Equity, Ethics 2-4 May 2011 The Franklin Institute Science Museum. Philadelphia, USA Global Vaccines 202X:
Recommendations on IAP Immunization Time Table for 2012 Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI December 24 th, 25.
ICH-GCG June 2009 Pan American Health Organization CURRENT STATUS OF PAN AMERICAN NETWORK FOR DRUG REGULATORY HARMONIZATION (PANDRH): James Fitzgerald.
1 EEC Board Policy and Research Committee October 2, 2013 State Advisory Council (SAC) Sustainability for Early Childhood Systems Building.
APHA National Congress Dr Michael Smith Clinical Director 17 October 2011.
BASEL COMMITTEE ON BANKING SUPERVISION 1 Cross-Border Supervisory Cooperation under the Revised Basel Core Principles and Basel II 6th Annual International.
BRINGING ALL THE PARTNERS TO THE TABLE FOR THE GOOD OF THE STUDENTS AND THE COMMUNITY! Establishing a Regional Industry Intern Project.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Civil Society in Decision Making for Immunization Policies: the example of National Immunization Technical Advisory Groups (NITAGs) Center for Vaccine.
Involving the Whole Organization in Creating or Restructuring a Volunteer Program Louise DeIasi DeCava Consulting.
Diploma of Project Management Course Outline NSW Course Number Qualification Code BSB51407.
Overview.  Accreditation is both a status and a process  Status:  Status: Accreditation provides public notification that standards of quality are.
Ministry of Education Update BCSSA SUMMER ACADEMY August 21, 2015.
Towards the Development of Health Promotion Competencies Laying the Foundation for Discipline-Specific Competency Development Marco Ghassemi, MSc Chronic.
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Survey of KAP of Pediatricians regarding Hib Disease & Vaccination in India during Pedicon Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI
Pharmacovigilance Programme of India
DPG HEALTH MEETING USAID CONFERENCE ROOM 6 NOVEMBER 2013 International Health Regulation (2005)
 Introduction  What is CPD?  Principles of CPD  CPD Activities  The NSM’s role  Benefits of CPD  Foundations of a CPD system.
Roles and Responsibilities Of the library trustee NJLTA New Jersey Library Association.
Created by: Samuel Butt, Stacy Pease, and Ian Woglom.
Introduction of Hib in UIP Dr. Prashant P. Ghodam Moderator : Dr. Ranjan Solanki.
THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.
Briefing on Progress made with regard to Prevention and Management of Child Abuse and Neglect Especially Child Sexual Abuse Presentation at the Portfolio.
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
GOVERNOR’S EARLY CHILDHOOD ADVISORY COUNCIL (ECAC) September 9, 2014.
Assessment of recommendations of the 5 past ACHR sessions 26 th – 30 th Dulitha N. Fernando.
Global Strategy On Infant and Young Child Feeding State of Implementation in the context of MDG4 Country – India South Asia Breastfeeding Partners Forum.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
ATR on the minutes of last meeting December 21 st 2012 Annual Meeting of IAPCOI, The City Park Hotel, NCR Delhi Vipin M. Vashishtha, MD, FIAP Convener,
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
WHO EURO In Country Coordination and Strengthening National Interagency Coordinating Committees.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
A Regional Approach to Standardize Neonatal Deaths Surveillance in Latin America and the Caribbean (LAC) Dr. Goldy Mazia, MD, MPH Newborn Health Advisor;
Fifth Session of the Islamic Conference of Health Ministers Panel Discussion IV: NGO Involvement in the Improvement of Health Services in OIC Member Countries.
HIV AND INFANT FEEDING A FRAMEWORK FOR PRIORITY ACTIONS.
1 Strategic Plan Review. 2 Process Planning and Evaluation Committee will be discussing 2 directions per meeting. October meeting- Finance and Governance.
Annual Report Constitution Public Audit Act Public Finance Management Act Other legislation Minister of Finance Establishment and operations National.
Rotavirus vaccination: Issues & IAPCOI perspectives Vipin M. Vashishtha, MD, FIAP Convener, IAPCOI August 24 th & 25 th 2012.
2004 Pan American Health Organization Immunizations-PAHO Strengthening National Immunization Technical Advisory Groups in the Americas Jon K. Andrus Barbara.
Strategic Objective 4 To promote the exchange of experiences and regulatory knowledge between NRAs inside and outside PANDRH“ Lessons learned from international.
Children’s Policy Conference Austin, TX February 24, ECI as best practice model for children 0-3 years with developmental delays / chronic identified.
2010 James Fitzgerald Senior Advisor, Medicines and Health Technologies PAHO/WHO rd St Washington DC USA International Cooperation in Quality.
PROPOSED STRATEGIC PLANNING PROCESS DECEMBER 3, 2014 Port of Port Angeles.
Harmonised use of accreditation for assessing the competence of various Conformity Assessment Bodies Dr Andreas Steinhorst, EA ERA workshop 13 April 2016,
Building community trust and protecting public safety: the Australian national registration of Chinese medicine practitioners Prof Charlie Xue Chair, Chinese.
Finding a trainee position – advice and tips. If you have trouble finding a trainee position Make sure your CV stands out for the right reasons Your CV.
Regulatory and Reimbursement Harmonization An Industry Perspective Adrian Griffin | April 2016.
School Community Council Roles and Responsibilities
Purpose and Process of WHO guideline development
GETTING INVOLVED: VOLUNTEER OPPORTUNITIES AT CAEP
FDA Guidance for Industry and FDA Staff Summary of Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”) Effective: December.
HCS 449 Education for Service-- snaptutorial.com.
Monitoring and Evaluation using the
Background to The Conference
National Governing and Leadership Structure
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Curriculum Coordinator: Marela Fiacco Date : February 29, 2015
Health Technology Assessment in India
ADVAC ALUMNI MEETING DURING SAGE
THE SANAC RESEARCH SECTOR
Presentation transcript:

IAPCOI : Rollout plan Vipin M. Vashishtha, MD, FIAP Convener, July 16, 2011 IAP HQ, Mumbai

Plan of action: I. Objectives II. Operational issues III. Recommendations IV. Collaborations V. Future Activities: – Recommendations – Surveillance – Proposed new activities

I. Objectives & Scope of Activities* To issue guidelines to its members through publication of guidebook, updates in journals, website, etc on various issues related to vaccines and practice of immunization: To guide GOI on various issues related to constitution of NIP To guide GoI/ICMR through NTAGI on various issues related to introduction of a new vaccine in to its NIP. To extend IAP’s advocacy role in providing impetus to vaccination drive all over the country. To collaborate with MoH/ICMR/ health agencies in improving RI To collaborate with other IAP chapters/groups/ national agencies in gathering data on important VPDs To help national agencies to gather data on vaccine safety and AEFI To counteract any misinformation campaign against vaccines/vaccination *

II. Operational issues Structure of the committee: – Voting Vs non-voting members Meeting schedule: – Periodicity: Twice in a year: Jan/Dec & July – Venues: Mumbai & Delhi Recommendations: – Immunization schedule : preferably revised annually – Interim recommendations: As & when the need arises – Guidebook: once in every two years (in the end of the committee’s tenure)

II. Operational issues Publications: – Guidebook – Interim recommendations – Replies to vaccination queries – Position papers? – Proceeding & Recommendations (to website & Academy Today, etc after every meeting)

II. Operational issues “Code of Conduct” issues: Committee’s stand on “Conflict of interest” Code of Ethics Regulations, 2002; MEDICAL COUNCIL OF INDIA AMENDMENT NOTIFICATION New Delhi, the 10th December, 2009 (Available from:

II. Operational issues Division of Work/ Description of Duties: Assignment of jobs to each member – Data on individual vaccines: Surveillance Review of literature (national & global) Clinical trials: ongoing/planned/completed – Vaccinology in review Appointment of rapporteur

II. Operational issues Website: Needs improvement: ? Public information ? Interactive- Discussion Forum Meeting agenda, minutes, presentations ? Link to Idsurve: surveillance data posting Online courses ?

III. Recommendations Methodology of issuing recommendations: How to offer best evidence-based recommendations? Need to answer few questions: What is the evidence? – How to look for it? How to access? – How to assess & analyze? Which is the better evidence? (Hierarchy of evidence) How to grade the available evidence to issue recommendations?

III. Recommendations What are the models available? To develop a uniform approach to making explicit the evidence base for IAPCOI recommendations

III. Recommendations Focus on transparency Use of evidence of varying strengths Consider individual and community health Continually strive to improve the process Changes to existing recommendations? First apply proposed process to New recommendations ?

(GRADE) framework: Grades of Recommendation Assessment, Development and Evaluation (GRADE) framework

Description of Evidence Grades Proposed evidence grades for safety and efficacy, A, B, C, D June 2010 ACIP Meeting

Description of Evidence Grades: Note: Grades reflect the confidence in the estimated effect on health outcomes based on a body of evidence. Further research may not always be possible.

Proposed recommendation categories: Category I (recommendation for, or recommendation against) – Universal recommendation – Risk-based recommendation Category II (recommendation for individual clinical decision making) No recommendation/unresolved issue

Examples: Recommendation: ACIP recommends vaccination of U.S. infants with three doses of rotavirus vaccine administered orally at ages 2, 4, and 6 months (Recommendation category: I, Evidence grade: A). Remarks: Nearly every child in the U.S. is infected with rotavirus by age 5 years, resulting in approximately 410,000 physician visits, 205,000–272,000 emergency department visits, and 55,000–70,000 hospitalizations each year. Benefits of vaccination are large compared to potential harms.

Examples: IAPCOI recommends TWO/THREE doses of HRV/RV-5 administered orally at ages 6 & 10 OR 6, 10, 14 weeks (Category: ? Evidence: ? )

Examples: IAPCOI recommends OPV …… (Category: I Evidence: A ) IAPCOI recommendations on Typhoid vaccine: Vi-PS (Category: I ? Evidence: A/B ) Vi Conjugate (Category: II Evidence: C/D?)

Examples: Hepatitis A vaccines: Recommendations for use: (Category : ? ? Evidence: ? ) Killed vaccine: TWO doses (Category: I Evidence: A) Live H2 strain: TWO doses (Category: II ? Evidence: B/C )

IV. Collaborations Vaccine production & launch : Licensure: Recommendations on its utilization: – Community level (mass use) – Individual use level Ensure higher utilization/improving coverage Industry Regulatory authority GoI/NTAGI IAP Agencies & NGOs

IV. Collaborations With industry: Why? To maintain transparency To know: what’s going on? National, regional, global level? What we expect from them? What they expect from us? What’s happening once a new vaccine is introduced in the market? Data on utilization, PMS, etc? Can they help us in VPD surveillance? Collaborative research projects? Help in professional knowledge enhancement?

IV. Collaborations With NRA & GoI: Need to develop liaison with DCGI? Collaboration with GoI: on policy, implementation issues – NTAGI – IEAG – UIP managers – others

IV. Collaborations With Agencies & NGOs: WHO UNICEF Gates Foundation PATH/NPSP etc Immunize India

V. Activities: Current Bi-annual meetings Revision of IAP immunization schedule Reappraisals of previous recommendations Guidebook Drafting recommendations on any new issue Responding to vaccine-related issues & queries Maintenance of website

V. Activities: Future: Vaccine Congresses Online vaccinology course? Position papers? Brainstorming sessions/Single theme consultative meetings? Textbook of vaccinology?

V. Activities: Future: VPD surveillance: How to go about it? Structure (erecting & expanding the network) Idsurve ? Need to strengthen it Need other surveillance methodology to supplant ?

VPD Surveillance: COI Surveillance Committee: National & Joint-national coordinators Convener – Zonal coordinators State coordinators – Regional & District coordinators » Reporting units (Rus)

VPD surveillance: Data analysis: Need to analyze compiled data Periodicity? Annual/biannual? Interpretation Publication

THANK YOU!!